Preliminary Results of a Phase II Trial of Panobinostat (LBH589) In Refractory Myelodysplastic Syndromes (MDS) PatientsIan W. Flinn, John D. Hainsworth, Ines Macias‐Perez et al.|Blood|2010Cited by 8
Bendamustine, Bortezomib and Dexamethasone (BBD) As First-Line Treatment Of Patients (Pts) With Multiple Myeloma Who Are Not Candidates For High Dose ChemotherapyJesús G. Berdeja, Ian W. Flinn, Michael R. Savona et al.|Blood|2013Cited by 7